The RoyaLand Company (RLNDF) adds healthcare and football executive Nazario Matachione to board
Rhea-AI Filing Summary
The RoyaLand Company Ltd. appointed Nazario Matachione to its Board of Directors as of July 16, 2026, to serve until the earlier of his successor’s appointment or election, resignation, death, or removal. He is an Italian entrepreneur, corporate executive, licensed pharmacist, and strategic advisor with more than twenty-five years of leadership experience.
He previously transformed his family’s pharmacy from a 70-square-meter shop into a 500-square-meter healthcare and wellness center, expanding revenues from about €1 million to more than €7 million and later building a multi-pharmacy organization with €35 million in annual revenues. He has held roles in local government, economic development, professional football management, nutraceuticals, and strategic advisory, including leading a creditor-approved restructuring plan for his business group and serving as General Manager and Chief Operating Officer of Savoia 1908, The RoyaLand Company’s majority-owned football subsidiary.
Positive
- None.
Negative
- None.
Key Figures
Pharmacy expansion: 70-square-meter to 500-square-meter
Flagship pharmacy revenue growth: from approximately €1 million to more than €7 million
Multi-pharmacy organization revenue: €35 million
+2 more
5 metrics
Pharmacy expansion
70-square-meter to 500-square-meter
Size increase of family pharmacy under Matachione’s leadership
Flagship pharmacy revenue growth
from approximately €1 million to more than €7 million
Annual revenues of flagship pharmacy under Matachione
Multi-pharmacy organization revenue
€35 million
Annual revenues of integrated multi-pharmacy organization he created
Polaris nutraceutical revenue growth
from approximately €150,000 to nearly €800,000
Annual revenues within a single year at Polaris Farmaceutici’s nutraceutical division
Savoia 1908 promotions
two promotions within three competitive seasons
Performance at Savoia 1908 under Matachione as GM and COO
Key Terms
composition with creditors proposal, insolvency proceedings, nutraceutical division, dermocosmetics, +1 more
5 terms
composition with creditors proposal financial
"sponsor of his own composition with creditors proposal."
insolvency proceedings financial
"The successful approval of the plan ultimately led to the conclusion of the insolvency proceedings."
A formal legal process used when a company cannot pay its debts, where a court oversees how the company’s assets and obligations are handled — either by reorganizing the business to keep it operating or by selling assets to pay creditors. For investors this matters because it determines who gets paid first and how much, often reducing or wiping out shareholders’ value while giving higher priority to lenders, and it sets the timeline and likelihood of any recovery.
nutraceutical division medical
"he led the strategic development of the company’s nutraceutical division, increasing annual revenues"
dermocosmetics medical
"integrating pharmaceutical services with premium dermocosmetics, luxury fragrances, nutrition"
Products that sit between medicine and skincare, dermocosmetics are creams, serums and lotions formulated with active ingredients and clinical evidence to treat or prevent skin issues while also improving appearance. Investors care because these products often command higher prices, benefit from professional trust and repeat purchases, and face both consumer demand and regulatory scrutiny—making marketing, clinical data and distribution key drivers of sales and risk.
economic development corporation financial
"Board of Directors of Città del Fare S.C.p.A., a regional economic development corporation"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What board change did The RoyaLand Company (RLNDF) report in July 2026?
The RoyaLand Company appointed Nazario Matachione to its Board of Directors as of July 16, 2026. He will serve until the earlier of his successor’s appointment or election, resignation, death, or removal, expanding the board with extensive healthcare and restructuring experience.
Who is Nazario Matachione, the new director at RoyaLand (RLNDF)?
Nazario Matachione is an Italian entrepreneur, corporate executive, and licensed pharmacist with over 25 years of leadership in healthcare, pharmaceutical distribution, retail innovation, corporate governance, business development, and organizational transformation across multiple companies and public and private sector roles.
What healthcare and pharmaceutical experience does Matachione bring to RLNDF?
Matachione transformed a family pharmacy into a 500-square-meter healthcare and wellness center, raising revenues from about €1 million to more than €7 million, built a multi-pharmacy group with €35 million in revenues, and helped grow Polaris Farmaceutici’s nutraceutical division from about €150,000 to nearly €800,000 in one year.
What is Nazario Matachione’s connection to RoyaLand’s Savoia 1908 subsidiary?
Matachione helped establish CRH Royalty S., supporting the acquisition and development of Savoia 1908 Football Club, S., The RoyaLand Company’s 90% owned subsidiary. Since the 2023–2024 season he has served as Savoia 1908’s General Manager and Chief Operating Officer, leading organizational restructuring and achieving two promotions in three seasons.
What corporate restructuring experience does Nazario Matachione have relevant to RLNDF?
Beginning in 2014, Matachione personally designed and sponsored a composition with creditors proposal for his business group. His restructuring plan was approved by creditors, including Johnson & Johnson, prevailed over a competing plan, and led to the conclusion of the related insolvency proceedings.